通过脑脊液通道递送基因治疗以恢复成年小鼠听力
本研究探讨经脑脊液通路向内耳递送基因治疗的可行性。在成年小鼠中,经脑池注射携带Slc17A8的腺相关病毒,通过耳蜗导水管到达内耳,恢复成年聋鼠的听力,且脑和肝脏异位表达极少。
要点
- 小鼠耳蜗导水管具有类淋巴特征,大颗粒示踪剂经脑脊液可到达内耳。
- 单次经脑池注射AAV-Slc17A8可恢复成年Slc17A8-/-小鼠听力。
- 该途径为成年内耳基因递送提供可及路径,可能有助于人类听力恢复。
核心结论
- 脑脊液运输是向成年内耳递送基因的可及途径,可能代表使用基因治疗恢复人类听力的重要一步。
研究设计与样本
- 在成年小鼠中进行的在体研究,采用经脑池注射腺相关病毒及多种影像学示踪方法。
主要发现
- 小鼠耳蜗导水管表现出类淋巴特征。
- 在体延时磁共振成像、计算机断层扫描和光学荧光显微镜显示,注射入脑脊液的大颗粒示踪剂经耳蜗导水管以弥散运输方式到达成年小鼠内耳。
- 单次经脑池注射携带溶质载体家族17成员8(Slc17A8)的腺相关病毒,通过恢复内毛细胞中囊泡谷氨酸转运体3(VGLUT3)蛋白表达,挽救了成年Slc17A8-/-聋鼠的听力,脑内异位表达极少,肝脏无表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inner ear gene therapy has recently effectively restored hearing in neonatal mice, but it is complicated in adulthood by the structural inaccessibility of the cochlea, which is embedded within the temporal bone. Alternative delivery routes may advance auditory research and also prove useful when translated to humans with progressive genetic-mediated hearing loss. Cerebrospinal fluid flow via the glymphatic system is emerging as a new approach for brain-wide drug delivery in rodents as well as humans. The cerebrospinal fluid and the fluid of the inner ear are connected via a bony channel called the cochlear aqueduct, but previous studies have not explored the possibility of delivering gene therapy via the cerebrospinal fluid to restore hearing in adult deaf mice. Here, we showed that the cochlear aqueduct in mice exhibits lymphatic-like characteristics. In vivo time-lapse magnetic resonance imaging, computed tomography, and optical fluorescence microscopy showed that large-particle tracers injected into the cerebrospinal fluid reached the inner ear by dispersive transport via the cochlear aqueduct in adult mice. A single intracisternal injection of adeno-associated virus carrying solute carrier family 17, member 8 (Slc17A8), which encodes vesicular glutamate transporter-3 (VGLUT3), rescued hearing in adult deaf Slc17A8-/- mice by restoring VGLUT3 protein expression in inner hair cells, with minimal ectopic expression in the brain and none in the liver. Our findings demonstrate that cerebrospinal fluid transport comprises an accessible route for gene delivery to the adult inner ear and may represent an important step toward using gene therapy to restore hearing in humans.
引用
- Mathiesen BK, Miyakoshi LM, Cederroth CR, et al. Delivery of gene therapy through a cerebrospinal fluid conduit to rescue hearing in adult mice. Sci Transl Med. 2023. PMID: 37379370. doi:10.1126/scitranslmed.abq3916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。